METHADONE VS. NON-METHADONE PATIENTS IN A THERAPEUTIC COMMUNITY: TEST OF EQUIVALENCY James L. Sorensen 1,2, S. Andrews 1,2, K. L. Delucchi 1,3, B. Greenberg.

Slides:



Advertisements
Similar presentations
Alcohol screening and brief intervention delivery to an Irish cohort of opiate dependent methadone maintained patients. Catherine Darker (PhD) Department.
Advertisements

Background: The low retention rates among African Americans in substance abuse treatment (Milligan et al., 2004) combined with the limited number of treatments.
Substance Use: Substance use comparisons included lifetime and past 30 day use (Figure 3) and lifetime use. For past 30 day use, more men reported heroin.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2014.
1 Towards Successful Treatment Completion A good practice guide Dr John Dunn Consultant Psychiatrist and NTA Clinical Team Leader Effective treatment,
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2013.
Behavioral Intention and Partner Type on Condom Use Among Men in Drug Treatment Yong S. Song, PhD, University of California, San Francisco Donald Calsyn,
HIV Risk Behaviors and Alcohol Intoxication among Injection Drug Users in Puerto Rico Tomás D. Matos, MS Center for Addiction Studies Universidad Central.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2008.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2011.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2009.
Motivational Interviewing to Improve Treatment Engagement and Outcome* The effect of one session on retention Research findings from the NIDA Clinical.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2008.
TREATING SPECIAL POPULATIONS. OVERVIEW Tobacco Treatment Smoking Outcomes Co-occurring Disorders Integration Tobacco Prevention.
OVBIAGELE B, DIENER H-C, YUSUF S, ET AL., PROFESS INVESTIGATORS. LEVEL OF SYSTOLIC BLOOD PRESSURE WITHIN THE NORMAL RANGE AND RISK OF RECURRENT STROKE.
Methods Results ASAT Extract of Objectives COBRA*: 1-Year Retention and Outcome of Methadone and Buprenorphine Maintenance in Different Care Settings in.
Addressing Crystal Methamphetamine Use Among Gay and Bisexual Men: A Treatment Center’s Response Joe Ruggiero, Ph.D. –Director, Outpatient Services The.
Slide 1 of 20 Overview of National Treatment Outcome Studies Charts Prepared & Released for Public Use by Dwayne Simpson (TCU), Robert Hubbard (NDRI-NC),
Treatment Program Perspectives: Conducting Research in the NIDA Clinical Trials Network Yong S. Song, PhD.
Substance Abuse Treatment. PROFILE OF A DRUG ABUSER  MOST PEOPLE IN TREATMENT ARE BETWEEN YEARS OF AGE  MANY DRUG ABUSERS SUFFER FROM MENTAL HEALTH.
HEALTHRIGHT 360 Residential Problem Gambling Treatment Program.
Low-Cost Contingency Management in Community Settings
Substitution treatment of opioid dependent Patients in Routine Care in Germany: Retention Rates after 12 Months of Follow-up (COBRA*) H.-U. Wittchen, S.
HIV Risk Reduction With Buprenorphine- Naloxone or Methadone: Findings From A Randomized Trial G. Woody, D. Bruce, P. T. Korthuis, S. Chhatre, M. Hillhouse,
Residential Treatment: What’s Methadone Got To Do With It? Siara Andrews, Psy.D. 1 Yong S. Song, Ph.D. 1 Steve Myers 2 University of California at San.
Behavioral Interventions for HIV Risk Reduction and HIV Prevention: An International Perspective Marek C. Chawarski Yale University School of Medicine.
SUBSTANCE USE DISORDERS GENERAL METHODS OF TREATMENT Inpatient Detoxification and Rehabilitation Outpatient Individual, Couple, or Family Counseling Self-help.
Attractive Addiction Treatment...? Can we make addiction treatment engaging?
Audrey J. Brooks, PhD University of Arizona CA-AZ node.
Frequency and type of adverse events associated with treating women with trauma in community substance abuse treatment programs T. KIlleen 1, C. Brown.
Greenberg&Cohen EBCRP Methamphetamine: Understanding the Influence of Violence in Treatment Planning and Recovery Judith Cohen, PhD Rivka Greenberg, PhD.
The Addiction Severity Index (ASI) Across Cultures TRI science addiction 2005 NIDA International Forum June 17th, 2005 Workshop II - The Ireland Room B.
Medication Assisted Therapy for Opioid Addiction: Methadone and Buprenorphine Andrew J. Saxon, M.D. Veterans Affairs Puget Sound Health Care System and.
C:\laam\lamAPA.ppt 8/04/98 Heroin Addiction Treatment: A Comparison of Methadone and LAAM M. Douglas Anglin, Ph.D. Douglas Longshore, Ph.D. Jeffrey J.
FUTURE HIV RESEARCH EFFORTS PLANNED FOR THE CLINICAL TRIALS NETWORK James L. Sorensen, Ph.D. Susan Tross, Ph.D. Raul Mandler, M.D. University of California,
Specific Aims  Modify a previously used ACASI (audio computer assisted structured interview) assessment tool, the Sexual Behavior Inventory (SBI), for.
MIA: STEP Toolkit Overview. NIDA-SAMHSA Blending Initiative 2 What is an MI Assessment?  Use of client-centered MI style  MI strategies that can be.
WORK PACKAGE TREATMENT CHALLENGES Dr.Thomas Legl Member of Executive Committee EURO –TC Director Kur- und Gesundheitszentrum Knappenhof/Austria ICAA,,
Module IV: Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals.
Criminal Justice Referral and Incentives in Outpatient Substance Abuse Treatment Anthony DeFulio 1, Paul Nuzzo 2, & Maxine Stitzer 1 1 – Johns Hopkins.
HIV TESTING IN DRUG ABUSE TREATMENT James L. Sorensen, Ph.D. University of California, San Francisco and San Francisco General Hospital Presentation at.
Raymond F. Anton, MD for The COMBINE Study Research Group
Participants were recruited from 6 drug free, psychosocial treatment (PT) and 5 methadone maintenance (MM) programs (N = 628) participating in a NIDA Clinical.
History and Background Formed in 2006 as a joint collaboration of San Mateo County Courts, Probation Department, District Attorney Office, Sheriff’s Office,
Abstinence Incentives for Methadone Maintained Stimulant Users: Outcomes for Those Testing Stimulant Positive vs Negative at Study Intake Maxine L. Stitzer.
Clinical Management of Substance Misuse Dave Marteau Prison Health
Introduction Results and Conclusions On demographic variables, analyses revealed that ATR clients were more likely to be Hispanic and employed, whereas.
Slide 1 of 19 National Treatment Retention Findings from DATOS Charts Prepared & Released for Public Use by Dwayne Simpson (TCU), Robert Hubbard (NDRI-NC),
Positive Prevention for HIV+ Injection Drug Users Kelly Knight, Debra Allen, Caryn Pelegrino, Barbara Garcia and Jeff Moore.
UCLA Integrated Substance Abuse Programs Amity In-Prison Therapeutic Community: Five-Year Outcomes Association of Criminal Justice Research (CA) Sacramento,
Abstinence Incentive Effects in Psychosocial Counseling Patients Testing Stimulant Positive vs Negative at Treatment Entry Maxine L. Stitzer Johns Hopkins.
Table 1. Prediction model for maximum daily dose of buprenorphine-naloxone in a 12-week treatment condition Baseline Predictors Maximum Daily Dose Standardized.
Treatment-related reduction in HIV sexual risk behavior: A CTN secondary analysis T Killeen 1, R Carter 1, M Stitzer 2, G Woody 3, M Copersino 4, J Roll.
Module IV - Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS.
Teaching Condom Use Skills: Practice is Superior to Observation Donald Calsyn, Ph.D. 1,2, Melinda Godinez, M.S.W. 3, Suzanne R. Doyle, Ph.D. 1, Mary Hatch-Maillette,
Predictors of study retention in addiction treatment trials KORTE JE 1, MAGRUDER KM 1,2, KILLEEN TK 1, SONNE SC 1, SAMPSON RR 1 and BRADY KT 1,2 1. Medical.
BEHAVIORAL FAMILY COUNSELING AND NALTREXONE FOR MALE OPIOID-DEPENDENT PATIENTS William Fals-Stewart, Ph.D. Research Institute on Addictions.
Cleveland Municipal Drug Court: SAMHSA CSAT Adult Treatment Drug Court Grant Dr. Margaret Baughman Madison Wheeler, BS Paul Tuschman, BA Begun.
Howard Newville 1, James L. Sorensen 1, Donald A. Calsyn 2 1 University of California, San Francisco, San Francisco, CA 2 University of Washington, Seattle,
Results: Objective 2 Nicholas C. Heck 1, Lucas A. Mirabito 1, Kelly LeMaire 1, Nicholas A. Livingston 2, and Annesa Flentje 3 Abstract Objective: The present.
Methadone maintenance in Michigan: Five years of data using a contingency management approach Gary Rhodes, M.A., L.L.P. Golfo Tzilos, M.A. Mark Greenwald,
Suboxone and Opioid Trends Joseph Merrill M.D., M.P.H. University of Washington June 16, 2009.
Rev In the Diffusion of Innovations Everyone Changes: Linking Practice with Scientific Research James L. Sorensen, Ph.D. University of California,
Ch. 17 Preventing Drug Abuse Section 4 Choosing to be Drug Free.
Hatch-Maillette, M. 1, Calsyn, D. A1,2, Doyle, S. 1, Woods, A
Turning Challenges into Opportunities
David Sottile, Anthony DeFulio, and Kenneth Silverman INTRODUCTION
Sherry Deren, Sung-Yeon Kang, Milton Mino & Honoria Guarino
JAMA Ophthalmology Journal Club Slides: Effect of Oral Voriconazole on Fungal Keratitis Prajna NV, TKrishnan T, Rajaraman R, et al; Mycotic Ulcer Treatment.
The relationship between incarceration and opioid addiction treatment
Presentation transcript:

METHADONE VS. NON-METHADONE PATIENTS IN A THERAPEUTIC COMMUNITY: TEST OF EQUIVALENCY James L. Sorensen 1,2, S. Andrews 1,2, K. L. Delucchi 1,3, B. Greenberg 2, J. Guydish 1, and C. L. Masson 1,2 1 University of California San Francisco, 2 San Francisco General Hospital, 3 Walden House, Inc. San Francisco, CA INTRODUCTION METHODS RESULTS SUMMARY ACKNOWLEDGEMENTS Figure 1: Survival curves show days of retention in treatment were equivalent for both groups Figure 2: Illicit opiate use increased over time in both groups Primary Hypotheses: As expected, the MMT and comparison groups were statistically equivalent on retention in the TC (mean of days for the MMT group, versus mean of days for the comparison group). At each assessment, the proportion of the MMT group testing positive for illicit opiates was indistinguishable from the proportion in the comparison group. Follow Up Rates: The follow-up rates for the 6, 12, 18, and 24-month assessments were 95% 94%, 90% and 87% respectively for the MMT group and 96%,92%, 91% and 82% respectively for the comparison group. Participants: 125 MMT and 106 non-MMT clients who entered the TC. Clients in both groups were opiate-dependent and matched on psychiatric history, criminal justice pressure, and expected length of stay in the TC. TC Program Modifications: The treatment setting made several modifications to accommodate MMT clients, including a weekly methadone group, and easier access to alternative therapies and psychiatric services 1. Assessments: Structured interviews were conducted at baseline and 6, 12, 18, and 24 months. Hypotheses: Primary hypotheses were that retention in the TC and illicit opiate use would be equivalent between the MMT and comparison groups. Secondary hypotheses were that stimulant, benzodiazepine, and alcohol use—as well as HIV risk behaviors and criminal behaviors---would be equivalent between the groups. Residential therapeutic communities (TCs) have demonstrated effectiveness, yet for the most part they adhere to a drug-free ideology that is incompatible with methadone maintenance treatment (MMT). This study compared MMT to non-MMT patients enrolled in a TC, testing the hypothesis that the two groups were equivalent. Supported by NIH Research Grants, R01DA014922, P50DA09253 (San Francisco Treatment Research Center), U10DA15815 (CA-AZ Clinical Trials Network Node), and K01DA00408 (Dr. Masson). Gratitude to the staff and patients of Walden House, Inc. and the Opiate Treatment Outpatient Program (San Francisco General Hospital) in carrying out the study. The findings indicate that MM clients fared as well as other opiate users in TC treatment. The study provides additional evidence that TCs can be successfully modified to accommodate methadone- maintained patients. Study limitations include that clients were not randomly assigned to MMT or comparison groups and the TC was modified to accommodate MMT patients. Additional research is needed to assess the impact of integration of MMT services in the TC setting, specifically the impact on patients and staff, and to explore the use of buprenorphine in TC settings. Secondary Hypotheses: The equivalence found for illicit opiate use was also found for each stimulant and alcohol use. The groups were statistically equivalent for benzodiazepine use at all assessments except at 24 months, where 7% of the MMT group versus none in the comparison group tested positive. Regarding injection- and sex-risk behaviors, the groups were equivalent at all observation points. RESULTS CONTINUED REFERENCE 1 Greenberg, B., Hall, D. H., Sorensen, J. L., Methadone maintenance therapy in residential therapeutic community settings: Challenges and promise. J Psychoactive Drug. 39,